Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19, 2026, Ray et al

[Covidivici]

Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19

Spoiler: Authors

Ray, Urvi; Schulze Selting, Antje; Perera, Roshan Priyarangana; Yang, Zhiqi; Lysenkov, Vladislav; Göpel, Siri; Bitzer, Michael; Salker, Madhuri S.; Ossowski, Stephan; Riess, Olaf; Casadei, Nicolas; Singh, Yogesh

Abstract
Introduction Long-term COVID-19 syndrome (LTCS) or “long COVID” is a debilitating post-viral condition affecting approximately 2%–8% of individuals after SARS-CoV-2 infection. It manifests typically ≥3 months post-infection with symptoms persisting for at least 2 months, including fatigue, pulmonary dysfunction, and cognitive impairment, in the absence of alternative diagnoses. The biological mechanisms underlying LTCS remain poorly defined, yet emerging evidence implicates immune dysregulation.

Methods We profiled plasma antibodies and cytokines from healthy controls (HC, N = 66), convalescents (CONV, N = 24), and LTCS patients ( N = 94), followed by multiparametric 14-color flow cytometry of PBMCs from HC ( N = 9), CONV ( N = 6), and LTCS ( N = 23) participants. To gain mechanistic insight, we performed single-cell transcriptomic profiling (scRNA-seq) on PBMCs from HC ( N = 8), CONV ( N = 6), and LTCS ( N = 32) individuals.

Results LTCS patients exhibited elevated anti-SARS-CoV-2 IgG (spike S1/RBD/N) titers compared with HC, but displayed significantly reduced systemic cytokine levels, including IFN-γ, TNF-α, IL-6, and IL-10. Flow cytometry revealed marked depletion of CD56 + CD16 + NK cells and CD56 + CD3 + NKT cells, accompanied by altered T-cell activation states. scRNA-seq confirmed NK type I cell loss and uncovered broad transcriptional reprogramming with upregulation of PDCD4 , CHD1 , CXCR4 , and SLC7A5 and downregulation of TGFBR3 , RIPOR2 , and MBNL1 . Gene set enrichment analyses indicated activation of circadian and translational programs and suppression of olfactory receptor, neurotransmitter receptor, and GABA-gated ion-channel pathways. Functional assays validated reduced NK-cell inflammatory capacity in LTCS participants.

Discussion LTCS is characterized by systemic cytokine attenuation and a quantitative and functional NK-cell deficit coupled to neurosensory pathway suppression. These findings identify NK cells as key sentinels of LTCS pathophysiology and highlight an NK-centric neuroimmune axis as a promising target for biomarker discovery and therapeutic intervention.

Web | DOI | PDF | Frontiers in Immunology

 

[Covidivici]

Harry Spoelstra on Ex-Twitter:

Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19

Long COVID's crippling fatigue, lost smell & brain fog now traced to profoundly exhausted & depleted NK cells, maybe unlocking a precise immune target for real treatments at last. A further IMPORTANT confirmation! #LEONARDI_EFFECT

This German study on long-term COVID-19 syndrome (LTCS, or long COVID) identifies immune dysregulation, centred on natural killer (NK) cells, as a driver of persistent symptoms like fatigue, pulmonary issues, and cognitive impairment in 2%–8% of SARS-CoV-2 survivors.

IMPORTANT FINDINGS:

• LC patients show sustained high anti-SARS-CoV-2 IgG titers (S1/RBD/N proteins) up to 500 days post-infection, similar to convalescents, but with markedly reduced systemic cytokines (e.g, IFN-γ, TNF-α, IL-6, IL-10, IL-8), signalling immune suppression rather than hyperinflammation
• Flow cytometry reveals depletion of CD56+ CD16+ NK cells and CD56+ CD3+ NKT cells in LTCS compared to healthy controls and convalescents, alongside altered T-cell activation states
• Single-cell RNA sequencing confirms NK cell loss and profound transcriptional changes (455 differentially expressed genes: 115 upregulated like PDCD4 and CXCR4, 340 downregulated like TGFBR3 and MBNL1)
• Single-cell RNA-seq reveals NK-cell exhaustion and impaired neuronal/sensory pathways and links immune dysfunction to hallmark symptoms such as fatigue, loss of smell, and cognitive impairment
• Enriched NK pathways include circadian rhythm regulation and translational programs.
• Suppressed ones involve olfactory perception, neurotransmitter/GABA signalling, and sensory smell, linking to neuroimmune dysfunction.
• Functional validation shows impaired NK cell inflammation (reduced TNF-α), mirroring chronic viral exhaustion and contributing to symptoms via a neuroimmune axis
• Vaccination and reinfection are not discussed as factors influencing NK-cell dysregulation or long COVID persistence
• Some valid limitations mentioned. This groundbreaking study reveals that dysregulated, exhausted natural killer (NK) cells, with profound depletion, transcriptional rewiring, and impaired function, directly drive the debilitating, persistent symptoms of long COVID, linking immune exhaustion to neuro-sensory and fatigue pathways!

So, according to this study, dysregulated NK cells fundamentally underpin long COVID's enduring pathology, calling for urgent NK-targeted interventions to avoid lifelong suffering for millions. #LongCOVID #NKcells #Immunology #AVOIDSARS2
https://threadreaderapp.com/thread/2030951652866371967.html

 

[Covidivici]

Zdenek Vrozina on Ex-Twitter:

Rather than framing long COVID as a simple state of persistent systemic inflammation, this new study points toward a model of chronically dysregulated immunity in which NK-cell dysfunction may occupy a central mechanistic role

This paper says something important. In at least a subset of patients, long COVID may represent a state of impaired, inefficient, and partly exhausted immune surveillance, with NK cells at its center.

The authors support this with three layers of evidence. SARS-CoV-2 antibodies persist in the blood, while key cytokines fall, NK/NKT cells are reduced in number, and the NK cells that remain carry transcriptional signatures of functional remodeling and suppression.

The first point is that the study shifts the picture of long COVID away from the simple idea of persistent systemic inflammation toward a model of chronically dysregulated immunity.

If this were pure hyperinflammation, we would expect persistently elevated pro-inflammatory mediators. Instead, IFN-γ, TNF-α, IL-6, and IL-10 all decline - meaning not only inflammatory drivers but also regulatory brakes are reduced.

The authors themselves describe it as a dampened, hyporesponsive state resembling a prolonged refractory phase or immune exhaustion.

The second point is that NK cells are not just one more marker among many here. They are a candidate nodal mechanism. NK cells are part of the early antiviral defense, but they are also a regulatory bridge between innate and adaptive immunity.

If their numbers fall and they produce less TNF-α, that may mean the host is less able to recognize and clear residual pathological signals - whether those are persistent antigens, tissue damage, or self-sustaining immune activation.

The third point is that the paper suggests long COVID is not simply more of the same after infection. Some changes are shared with ordinary convalescence, but others point more specifically to a failure to return to baseline.

This includes, above all, poorer coordination between innate and adaptive immunity and incomplete resolution of activation.

The fourth point is the link to neurological and sensory symptoms, which is particularly interesting. In NK cells, the authors identify suppression of pathways related to smell, taste, neurotransmitter receptors, and GABA signaling.

It suggests that the gene programs of these cells reflect a broader neuroimmune reorganization of the organism.

So the immune system is no longer just a defensive apparatus. It becomes an imprint of a systemic disorder that may clinically manifest as fatigue, anosmia, and brain fog. This is a bold but biologically interesting interpretation.

The fifth point is that elevated antibodies together with reduced cellular functionality create a striking contrast. The humoral response persists, while cellular immune surveillance appears dampened.

The immune system remains chronically exposed to some stimulus, but instead of eliminating it effectively, it shifts into a maladaptive mode. That is compatible with antigen persistence, although the study does not prove antigen persistence on its own.

NK cells emerge in this study as a likely important node - not necessarily the only cause, but very plausibly one of the main mechanistic links.

Practically, this implies three things.

1. First, biomarkers of long COVID may not be limited to high inflammation, but may also include pathologically low or poorly coordinated immune responses.
2. Second, therapies aimed only at suppressing inflammation may not be appropriate for all patients. In some, the problem may theoretically be immune inefficiency rather than excess immune activity.
3. Third, it makes sense to look for immunological subtypes of long COVID rather than treating all patients as one biological group.

Sum:

This study interprets long COVID not as simple persistent inflammation, but as a disorder of failed immune reequilibration in which NK cells are faltering both as effectors and as regulators.

Insides:

One consistent signal in this long COVID cohort - persistent SARS-CoV-2 antibodies.
IgG against Spike S1, RBD and N remained elevated even months after infection - in some cases up to 500 days.

This suggests the immune system may still be sensing persistent antigen exposure long after acute disease.

Long COVID patients in this study did not show a classic hyperinflammatory profile.
Key cytokines - IFN-γ, TNF-α, IL-6 and IL-10 - were significantly reduced.

This pattern is more consistent with immune hyporesponsiveness or exhaustion rather than persistent inflammation.

Flow cytometry revealed reduced CD56+CD16 NK cells and CD56+ CD3NKT cells.
NK cells are essential for antiviral surveillance.

Their decline - together with altered expression of genes such as CXCR4, PDCD4 and SLC7A5 - suggests functional remodeling of the NK compartment.

Single-cell RNA-seq identified transcriptional changes in NK cells linked to neurosensory pathways.

Genes related to smell and neuronal signaling - including OR1L8, OR52H1, OMP and SLC6A3 - were downregulated.

This points toward a potential neuro-immune axis underlying anosmia and cognitive symptoms in long COVID.

https://threadreaderapp.com/thread/2031047660862349692.html

 

[V.R.T.]

Okay so what do we think, does this live up to the hype of these twitter posts?

 

[Jaybee00]

Okay so what do we think, does this live up to the hype of these twitter posts?

Twitter is always true, isn’t it?

 

[Covidivici]

Okay so what do we think, does this live up to the hype of these twitter posts?

Exactly what I'm wondering — especially given that I'm currently on Pirfenidone (or placebo)* as part of LC-Revitalize. Also curious as to why they'd publish with Frontiers. But that's another discussion altogether. For the record, I'm not giving the twats (twitterers?) any credence. Just thought it might be a good starting point for discussions. It's utterly out of my depth.

*The Pirfenidone (if it even is that) ain't doin' squat for my PEM / fatigue / brain fog. Does give me mild heartburn if I take it without food, so who knows. I'm half way through the 3 month trial. Doing it for science as I was tired of hitting dead-ends with my own case studies (anticoagulants, antivirals, SGB, etc) without it being properly recorded for posterity. And given that this is meant to address dysregulated immunity (and that rapamycin was the only thing that ever made me feel better - until I got reinfected, that is), I figured why not. This study's giving me some food for thought.

Also for the record, this is the first and probably last trial I go through until we know WTF we're even trying to correct. Sorry for the vibe: been a hard few months and I'm turning 50 in a few weeks. I was a mid-40s athlete when COVID kneecapped me. And this 'Long COVID Awareness Month' has been particularly illustrative of how unaware society is happy to remain.

Back to the topic of the day: Anything to this study? (I know what y'all are going to say: "Maybe")

 

[Hutan]

Back to the topic of the day: Anything to this study? (I know what y'all are going to say: "Maybe")

I'd go further to 'unlikely', although I have only read the abstract.

They don't seem to have defined long covid tightly - the issues in people with pulmonary dysfunction may not have much to do with the issues in people with ME/CFS type disease.

Natural killer cell numbers have been all over the place in studies, as have NK cell function. Similarly for cytokines. There are so many LC and ME/CFS studies that measure cytokines, each new researcher convinced there must be something to be gleaned from these measures. Similarly for anti-Covid IgG.

Maybe, if the paper suggests a lot of rigour in participant selection, and if the charts are really compelling. The abstract gives us no statistics.